U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

Ilatreotide was developed as a somatostatin receptor agonist with potential for treating gastroenteropancreatic tumors. It is an orally active pituitary and guts hormonal secretion inhibitor.

Approval Year

Unknown
139594
Patents

Patents

WO2014173759A1
7
Name Type Language
ILATREOTIDE
INN  
INN  
Official Name English
ilatreotide [INN]
Common Name English
Code System Code Type Description
CAS
119719-11-8
Created by admin on Sat Dec 16 01:33:03 GMT 2023 , Edited by admin on Sat Dec 16 01:33:03 GMT 2023
PRIMARY
FDA UNII
398F0EG823
Created by admin on Sat Dec 16 01:33:03 GMT 2023 , Edited by admin on Sat Dec 16 01:33:03 GMT 2023
PRIMARY
NCI_THESAURUS
C166660
Created by admin on Sat Dec 16 01:33:03 GMT 2023 , Edited by admin on Sat Dec 16 01:33:03 GMT 2023
PRIMARY
EVMPD
SUB08129MIG
Created by admin on Sat Dec 16 01:33:03 GMT 2023 , Edited by admin on Sat Dec 16 01:33:03 GMT 2023
PRIMARY
INN
6862
Created by admin on Sat Dec 16 01:33:03 GMT 2023 , Edited by admin on Sat Dec 16 01:33:03 GMT 2023
PRIMARY
PUBCHEM
72046
Created by admin on Sat Dec 16 01:33:03 GMT 2023 , Edited by admin on Sat Dec 16 01:33:03 GMT 2023
PRIMARY
ChEMBL
CHEMBL2104390
Created by admin on Sat Dec 16 01:33:03 GMT 2023 , Edited by admin on Sat Dec 16 01:33:03 GMT 2023
PRIMARY
SUBSTANCE RECORD
ILATREOTIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966